Evidence map›Paper›PMID 40776644›Full record

ReviewCurrent medicinal chemistry2026

Recent Advancement of Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis- A Review.

Yiting Lin, Peiru Wang, Xi Hu, Qinjia Wang, Quan Shi, Yanna Zhou, Ruisheng Liu, Xianbin Cai

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yiting LinDepartment of Gastroenterology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Peiru WangDepartment of Nursing, Shantou Central Hospital, Shantou, China.
Xi HuDepartment of Gastroenterology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Qinjia WangDepartment of Gastroenterology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Quan ShiDepartment of Gastroenterology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Yanna ZhouDepartment of Gastroenterology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Ruisheng LiuDepartment of Gastroenterology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Xianbin CaiDepartment of Gastroenterology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fecal Microbiota Transplantation (FMT) involves the transfer of gut microbiota from healthy donors to recipients, aiming to reestablish microbial equilibrium within the gastrointestinal tract. The human gut harbors a complex and diverse microbial ecosystem, comprising bacteria, viruses, and fungi, that is essential for maintaining intestinal homeostasis. Emerging evidence indicates a strong association between gut microbial dysbiosis and the pathogenesis of Ulcerative Colitis (UC). FMT has been shown to modulate microbial composition, alter immune signaling pathways, enhance intestinal barrier function, and influence the production of proinflammatory mediators, thereby affecting disease progression. This review critically examines the efficacy, safety, modulatory factors, combination therapies, and predictive strategies associated with FMT in the context of UC. The findings suggest that FMT represents a highly promising therapeutic modality for UC. Overall, this review aims to provide a comprehensive and impartial synthesis of current knowledge regarding FMT, offering deeper insights into its therapeutic potential and clinical applicability in UC management.

Indexed as

Colitis, UlcerativeFecal Microbiota TransplantationAnimalsDysbiosisGastrointestinal MicrobiomeHumansdysbiosisfecal microbiota transplantationgut microbiotainflammationtreatment efficacyUlcerative colitis

Identifiers

PMID40776644

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.